Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

NCT00423917 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: fulvestrant

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]